Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2020 Nov-Dec;14(6):1897-1904.
doi: 10.1016/j.dsx.2020.09.029. Epub 2020 Sep 28.

Effect of increased BMI and obesity on the outcome of COVID-19 adult patients: A systematic review and meta-analysis

Arto Yuwono Soeroto  1 , Nanny Natalia Soetedjo  2 , Aga Purwiga  3 , Prayudi Santoso  4 , Iceu Dimas Kulsum  4 , Hendarsyah Suryadinata  4 , Ferdy Ferdian  4
Affiliations
Meta-Analysis

Effect of increased BMI and obesity on the outcome of COVID-19 adult patients: A systematic review and meta-analysis

Arto Yuwono Soeroto et al. Diabetes Metab Syndr. 2020 Nov-Dec.

Abstract

Background and aims: Corona virus diseases 2019 (COVID-19) pandemic spread rapidly. Growing evidences that overweight and obesity which extent nearly a third of the world population were associated with severe COVID-19. This study aimed to explore the association and risk of increased BMI and obesity with composite poor outcome in COVID-19 adult patients.

Methods: We conducted a systematic literature search from PubMed and Embase database. We included all original research articles in COVID-19 adult patients and obesity based on classification of Body Mass Index (BMI) and composite poor outcome which consist of ICU admission, ARDS, severe COVID-19, use of mechanical ventilation, hospital admission, and mortality.

Results: Sixteen studies were included in meta-analysis with 9 studies presented BMI as continuous outcome and 10 studies presented BMI as dichotomous outcome (cut-off ≥30 kg/m2). COVID-19 patients with composite poor outcome had higher BMI with mean difference 1.12 (95% CI, 0.67-1.57, P < 0.001). Meanwhile, obesity was associated with composite poor outcome with odds ratio (OR) = 1.78 (95% CI, 1.25-2.54, P < 0.001) Multivariate meta-regression showed the association between BMI and obesity on composite poor outcome were affected by age, gender, DM type 2, and hypertension.

Conclusion: Obesity is a risk factor of composite poor outcome of COVID-19. On the other hand, COVID-19 patients with composite poor outcome have higher BMI. BMI is an important routine procedure that should always be assessed in the management of COVID-19 patients and special attention should be given to patients with obesity.

Keywords: Body mass index; Covid-19; Obesity; Poor outcome.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors declare that there is no conflict of interests regarding the publication of this paper.

Figures

Fig. 1
Fig. 1
Prisma flowchart.
Fig. 2
Fig. 2
Forest plot presented BMI as dichotomous outcome with cut-off ≥30 kg/m2. Subgroup analysis showed obesity was not associated with ICU admission (p = 0.21) but associated with other poor outcomes (p < 0.001). Overall, obesity was associated with composite poor outcomes (P < 0.001).
Fig. 3
Fig. 3
Forest plot presented with BMI as continuous outcome. Subgroup analysis showed ICU admission was not associated with BMI (p = 0.55), but higher BMI was associated with severe COVID-19 (p < 0.001) and other poor outcomes (p < 0.001). Overall, higher BMI was associated with composite poor outcomes (P < 0.001).
Fig. 4
Fig. 4
Meta-regression for increased BMI (A–D) and obesity (E–H) showed both the association of higher BMI and obesity were affected by age, DM type 2, hypertension, and gender.
Fig. 5
Fig. 5
Funnel Plot showed asymmetrical non-inverted funnel. Harbord’s test was conducted with p = 0.204.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. WHO. Coronavirus disease 2019 (COVID-19) situation report – 209. 2020.
    1. Kruglikov I.L., Scherer P.E. The role of adipocytes and adipocyte-like cells in the severity of COVID-19 infections. Obesity. 2020;28(7):1187–1190. - PMC - PubMed
    1. Ge H., Wang X., Yuan X., Xiao G., Wang C., Deng T., et al. The epidemiology and clinical information about COVID-19. Eur J Clin Microbiol Infect Dis. 2020:1–9. - PMC - PubMed
    1. Guo Y.-R., Cao Q.-D., Hong Z.-S., Tan Y.-Y., Chen S.-D., Jin H.-J., et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res. 2020;7(1):11. - PMC - PubMed
    1. Kulcsar K.A., Coleman C.M., Beck S.E., Frieman M.B. Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection. JCI Insight. 2019;4(20) - PMC - PubMed

MeSH terms